SEARCH

SEARCH BY CITATION

References

  • 1
    Davignon D, Martz E, Reynolds T, Kurzinger K, Springer TA. Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing. Proc Natl Acad Sci USA 1981; 78: 45354539.
  • 2
    Sanchez-Madrid F, Krensky AM, Ware CF et al. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci USA 1982; 79: 74897493.
  • 3
    Ostermann G, Weber KS, Zernecke A, Schroder A, Weber C. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 2002; 3: 151158.
  • 4
    Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994; 76: 301314.
  • 5
    Bachmann MF, McKall-Faienza K, Schmits R et al. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 1997; 7: 549557.
  • 6
    Grakoui A, Bromley SK, Sumen C et al. The immunological synapse: a molecular machine controlling T cell activation. Science 1999; 285: 221227.
  • 7
    Lee KH, Holdorf AD, Dustin ML, Chan AC, Allen PM, Shaw AS. T cell receptor signaling precedes immunological synapse formation. Science 2002; 295: 15391542.
  • 8
    Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998; 395: 8286.
  • 9
    Qi SY, Groves JT, Chakraborty AK. Synaptic pattern formation during cellular recognition. Proc Natl Acad Sci USA 2001; 98: 65486553.
  • 10
    Freiberg BA, Kupfer H, Maslanik W et al. Staging and resetting T cell activation in SMACs. Nat Immunol 2002; 3: 911917.
  • 11
    Huang J, Lo PF, Zal T et al. CD28 plays a critical role in the segregation of PKC theta within the immunologic synapse. Proc Natl Acad Sci USA 2002; 99: 93699373.
  • 12
    Pribila JT, Quale AC, Mueller KL, Shimizu Y. Integrins and T cell-mediated immunity. Annu Rev Immunol 2004; 22: 157180.
  • 13
    Sanders ME, Makgoba MW, Sharrow SO et al. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol 1988; 140: 14011407.
  • 14
    Lee WT, Vitetta ES. The differential expression of homing and adhesion molecules on virgin and memory T cells in the mouse. Cell Immunol 1991; 132: 215222.
  • 15
    Okumura M, Fujii Y, Takeuchi Y, Inada K, Nakahara K, Matsuda H. Age-related accumulation of LFA-1high cells in a CD8+CD45RAhigh T cell population. Eur J Immunol 1993; 23: 10571063.
  • 16
    Moy VT, Brian AA. Signaling by lymphocyte function-associated antigen 1 (LFA-1) in B cells: enhanced antigen presentation after stimulation through LFA-1. J Exp Med 1992; 175: 17.
  • 17
    Howard DR, Eaves AC, Takei F. Lymphocyte function-associated antigen (LFA-1) is involved in B cell activation. J Immunol 1986; 136: 40134018.
  • 18
    Fischer A, Durandy A, Sterkers G, Griscelli C. Role of the LFA-1 molecule in cellular interactions required for antibody production in humans. J Immunol 1986; 136: 31983203.
  • 19
    Owens T. A role for adhesion molecules in contact-dependent T help for B cells. Eur J Immunol 1991; 21: 979983.
  • 20
    Metzler B, Gfeller P, Bigaud M et al. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection. J Immunol 2004; 173: 70257036.
  • 21
    Yamagami S, Isobe M, Yamagami H, Hori J, Tsuru T. Rejection mechanism and immunosuppression by FK 506 and anti-leukocyte function associated antigen-1 antibody in concordant corneal xenotransplantation. Transplant Proc 1997; 29: 943944.
  • 22
    Rayat GR, Gill RG. Indefinite survival of neonatal porcine islet xenografts by simultaneous targeting of LFA-1 and CD154 or CD45RB. Diabetes 2005; 54: 443451.
  • 23
    Kavanaugh AF, Lightfoot E, Lipsky PE, Oppenheimer-Marks N. Role of CD11/CD18 in adhesion and transendothelial migration of T cells. Analysis utilizing CD18-deficient T cell clones. J Immunol 1991; 146: 41494156.
  • 24
    Hamann A, Jablonski-Westrich D, Duijvestijn A et al. Evidence for an accessory role of LFA-1 in lymphocyte-high endothelium interaction during homing. J Immunol 1988; 140: 693699.
  • 25
    Warnock RA, Askari S, Butcher EC, Von Andrian UH. Molecular mechanisms of lymphocyte homing to peripheral lymph nodes. J Exp Med 1998; 187: 205216.
  • 26
    Constantin G, Majeed M, Giagulli C et al. Chemokines trigger immediate beta2 integrin affinity and mobility changes: differential regulation and roles in lymphocyte arrest under flow. Immunity 2000; 13: 759769.
  • 27
    Andrew DP, Spellberg JP, Takimoto H, Schmits R, Mak TW, Zukowski MM. Transendothelial migration and trafficking of leukocytes in LFA-1-deficient mice. Eur J Immunol 1998; 28: 19591969.
  • 28
    Belperio JA, Keane MP, Burdick MD et al. Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome. J Clin Invest 2005; 115: 11501162.
  • 29
    Berlin PJ, Bacher JD, Sharrow SO, Gonzalez C, Gress RE. Monoclonal antibodies against human T cell adhesion molecules–modulation of immune function in nonhuman primates. Transplantation 1992; 53: 840849.
  • 30
    Vugmeyster Y, Kikuchi T, Lowes MA et al. Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin. Clin Immunol 2004; 113: 3846.
  • 31
    Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990; 144: 45794586.
  • 32
    Zuckerman LA, Pullen L, Miller J. Functional consequences of costimulation by ICAM-1 on IL-2 gene expression and T cell activation. J Immunol 1998; 160: 32593268.
  • 33
    Cai Z, Brunmark A, Jackson MR, Loh D, Peterson PA, Sprent J. Transfected Drosophilia cells as a probe for defining the minimal requirements for stimulating unprimed CD8+ T cells. Proc Natl Acad Sci USA 1996; 93: 1473614741.
  • 34
    Abraham C, Griffith J, Miller J. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand. J Immunol 1999; 162: 43994405.
  • 35
    Ragazzo JL, Ozaki ME, Karlsson L, Peterson PA, Webb SR. Costimulation via lymphocyte function-associated antigen 1 in the absence of CD28 ligation promotes anergy of naive CD4+ T cells. Proc Natl Acad Sci USA 2001; 98: 241246.
  • 36
    Bleijs DA, Van Duijnhoven GC, Van Vliet SJ, Thijssen JP, Figdor CG, Van Kooyk Y. A single amino acid in the cytoplasmic domain of the beta 2 integrin lymphocyte function-associated antigen-1 regulates avidity-dependent inside-out signaling. J Biol Chem 2001; 276: 1033810346.
  • 37
    Chatila TA, Geha RS, Arnaout MA. Constitutive and stimulus-induced phosphorylation of CD11/CD18 leukocyte adhesion molecules. J Cell Biol 1989; 109: 34353444.
  • 38
    Rovere P, Inverardi L, Bender JR, Pardi R. Feedback modulation of ligand-engaged alpha L/beta 2 leukocyte integrin (LFA-1) by cyclic AMP-dependent protein kinase. J Immunol 1996; 156: 22732279.
  • 39
    Wulfing C, Sjaastad MD, Davis MM. Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. Proc Natl Acad Sci USA 1998; 95: 63026307.
  • 40
    Bianchi E, Denti S, Granata A et al. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature 2000; 404: 617621.
  • 41
    Perez OD, Mitchell D, Jager GC et al. Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1. Nat Immunol 2003; 4: 10831092.
  • 42
    Kolanus W, Nagel W, Schiller B et al. Alpha L beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell 1996; 86: 233242.
  • 43
    Lyapina S, Cope G, Shevchenko A et al. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 2001; 292: 13821385.
  • 44
    Kurz T, Pintard L, Willis JH et al. Cytoskeletal regulation by the Nedd8 ubiquitin-like protein modification pathway. Science 2002; 295: 12941298.
  • 45
    Nicolls MR, Coulombe M, Yang H, Bolwerk A, Gill RG. Anti-LFA-1 therapy induces long-term islet allograft acceptance in the absence of IFN-gamma or IL-4. J Immunol 2000; 164: 36273634.
  • 46
    Nicolls MR, Coulombe M, Beilke J, Gelhaus HC, Gill RG. CD4-dependent generation of dominant transplantation tolerance induced by simultaneous perturbation of CD154 and LFA-1 pathways. J Immunol 2002; 169: 48314839.
  • 47
    Salomon B, Bluestone JA. LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. J Immunol 1998; 161: 51385142.
  • 48
    Jenks SA, Eisfelder BJ, Miller J. LFA-1 co-stimulation inhibits Th2 differentiation by down-modulating IL-4 responsiveness. Int Immunol 2005; 17: 315323.
  • 49
    Luksch CR, Winqvist O, Ozaki ME et al. Intercellular adhesion molecule-1 inhibits interleukin 4 production by naive T cells. Proc Natl Acad Sci USA 1999; 96: 30233028.
  • 50
    Da Silva M, Petruzzo P, Virieux S, Tiollier J, Badet L, Martin X. A primate model of renal ischemia-reperfusion injury for preclinical evaluation of the antileukocyte function associated antigen 1 monoclonal antibody odulimonab. J Urol 2001; 166: 19151919.
  • 51
    Cavazzana-Calvo M, Sarnacki S, Haddad E et al. Prevention of bone marrow and cardiac graft rejection in an H-2 haplotype disparate mouse combination by an anti-LFA-1 antibody. Transplantation 1995; 59: 15761582.
  • 52
    Bashuda H, Takazawa K, Tamatani T, Miyasaka M, Yagita H, Okumura K. Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506. Transplantation 1996; 62: 117122.
  • 53
    Miwa S, Isobe M, Suzuki J et al. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection. Surgery 1997; 121: 681689.
  • 54
    Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992; 255: 11251127.
  • 55
    Horimoto H, Ito T, Hayashi T, Miyasaka M, Nozawa M. Transplantation tolerance by a combined therapy with sulfatide, anti-LFA-1/ICAM-1 monoclonal antibodies and FK506 in rat cardiac transplantation. Transpl Int 1998; 11: S310—S312.
  • 56
    Harrison PC, Madwed JB. Anti-LFA-1 alpha reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted rats. J Heart Lung Transplant 1999; 18: 279284.
  • 57
    Corbascio M, Mahanty H, Osterholm C et al. Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice. Transplantation 2002; 74: 3541.
  • 58
    Poston RS, Robbins RC, Chan B et al. Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients. Transplantation 2000; 69: 20052013.
  • 59
    Corbascio M, Ekstrand H, Osterholm C et al. CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely. Transpl Immunol 2002; 10: 5561.
  • 60
    Morikawa M, Brazelton TR, Berry GJ, Morris RE. Prolonged inhibition of obliterative airway disease in murine tracheal allografts by brief treatment with anti-leukocyte function-associated antigen-1 (CD11a) monoclonal antibody. Transplantation 2001; 71: 16161621.
  • 61
    Murakawa T, Kerklo MM, Zamora MR et al. Simultaneous LFA-1 and CD40 ligand antagonism prevents airway remodeling in orthotopic airway transplantation: implications for the role of respiratory epithelium as a modulator of fibrosis. J Immunol 2005; 174: 38693879.
  • 62
    Nakao Y, Mackinnon SE, Strasberg SR et al. Immunosuppressive effect of monoclonal antibodies to ICAM-1 and LFA-1 on peripheral nerve allograft in mice. Microsurgery 1995; 16: 612620.
  • 63
    Genden EM, Mackinnon SE, Yu S, Flye MW. Induction of donor-specific tolerance to rat nerve allografts with portal venous donor alloantigen and anti-ICAM-1/LFA-1 monoclonal antibodies. Surgery 1998; 124: 448456.
  • 64
    Larsson LC, Corbascio M, Widner H, Pearson TC, Larsen CP, Ekberg H. Simultaneous inhibition of B7 and LFA-1 signaling prevents rejection of discordant neural xenografts in mice lacking CD40L. Xenotransplantation 2002; 9: 6876.
  • 65
    Isobe M, Suzuki J, Yamazaki S, Sekiguchi M. Acceptance of primary skin graft after treatment with anti-intercellular adhesion molecule-1 and anti-leukocyte function-associated antigen-1 monoclonal antibodies in mice. Transplantation 1996; 62: 411413.
  • 66
    He Y, Mellon J, Apte R, Niederkorn JY. Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival. Invest Ophthalmol Vis Sci 1994; 35: 32183225.
  • 67
    Hori J, Isobe M, Yamagami S, Mizuochi T, Tsuru T. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Exp Eye Res 1997; 65: 8998.
  • 68
    Kato Y, Yamataka A, Yagita H, Bashuda H, Okumura K, Miyano T. Prevention of fetal bowel allograft rejection by combined treatment with anti-ICAM-1 and anti-LFA-1 antibodies. J Pediatr Surg 1995; 30: 10931097.
  • 69
    Bowles MJ, Pockley AG, Wood RF. Effect of anti-LFA-1 monoclonal antibody on rat small bowel allograft survival and circulating leukocyte populations. Transpl Immunol 2000; 8: 7580.
  • 70
    Gotoh M, Fukuzaki T, Monden M et al. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation. Transplantation 1994; 57: 123126.
  • 71
    Nishihara M, Gotoh M, Ohzato H et al. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts. Transplantation 1997; 64: 965970.
  • 72
    Arai K, Sunamura M, Wada Y et al. Preventing effect of anti-ICAM-1 and anti-LFA-1 monoclonal antibodies on murine islet allograft rejection. Int J Pancreatol 1999; 26: 2331.
  • 73
    Nicolls MR, Coulombe M, Diamond AS, Beilke J, Gill RG. Interferon-gamma is not a universal requirement for islet allograft survival. Transplantation 2002; 74: 472477.
  • 74
    Grochowiecki T, Gotoh M, Dono K et al. Induction of unresponsiveness to islet xenograft by MMC treatment of graft and blockage of LFA-1/ICAM-1 pathway. Transplantation 2000; 69: 15671571.
  • 75
    Berney T, Pileggi A, Molano RD et al. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice. Transplantation 2003; 76: 16691674.
  • 76
    Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Gray GS, Vallera DA. Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts. Blood 1995; 85: 26072618.
  • 77
    Wang Y, Gao D, Lunsford KE, Frankel WL, Bumgardner GL. Targeting LFA-1 synergizes with CD40/CD40L blockade for suppression of both CD4-dependent and CD8-dependent rejection. Am J Transplant 2003; 3: 12511258.
  • 78
    Guerette B, Skuk D, Celestin F et al. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J Immunol 1997; 159: 25222531.
  • 79
    Hasegawa Y, Yokono K, Taki T et al. Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb. Int Immunol 1994; 6: 831838.
  • 80
    Chowdhury SA, Nagata M, Yamada K et al. Tolerance mechanisms in murine autoimmune diabetes induced by anti-ICAM-1/LFA-1 mAb and anti-CD8 mAb. Kobe J Med Sci 2002; 48: 167175.
  • 81
    Honey K, Cobbold SP, Waldmann H. CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression. J Immunol 1999; 163: 48054810.
  • 82
    Trambley J, Bingaman AW, Lin A et al. Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 17151722.
  • 83
    Konieczny BT, Dai Z, Elwood ET et al. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160: 20592064.
  • 84
    Larsen CP, Elwood ET, Alexander DZ et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434438.
  • 85
    Grazia TJ, Gill RG, Gelhaus HC, Doan AN, Sleater ML, Pietra B. Perturbation of leukocyte-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac versus islet allograft survival. J Heart Lung Transplant 2005; 24: 14101414.
  • 86
    Cavazzana-Calvo M, Bordigoni P, Michel G et al. A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Societe Francaise de Greffe de Moelle Osseuse. Br J Haematol 1996; 93: 131138.
  • 87
    Maraninchi D, Mawas C, Stoppa AM et al. Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adults. Bone Marrow Transplant 1989; 4: 147150.
  • 88
    Le Mauff B, Hourmant M, Rougier JP et al. Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation. Transplantation 1991; 52: 291296.
  • 89
    Hourmant M, Bedrossian J, Durand D et al. A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations. Transplantation 1996; 62: 15651570.
  • 90
    Benfield MR, Tejani A, Harmon WE et al. A randomized multicenter trial of OKT3 mAbs induction compared with intravenous cyclosporine in pediatric renal transplantation. Pediatr Transplant 2005; 9: 282292.
  • 91
    Werther WA, Gonzalez TN, O'Connor SJ et al. Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1. J Immunol 1996; 157: 49864995.
  • 92
    Vincenti F. What's in the pipeline? New immunosuppressive drugs in transplantation. Am J Transplant 2002; 2: 898903.
  • 93
    Meier-Kriesche HU, Schold JD, Srinivas TR, Howard RJ, Fujita S, Kaplan B. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 2005; 5: 22732280.
  • 94
    Gabrijelcic J, Acuna A, Profita M et al. Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression. Eur Respir J 2003; 22: 290297.
  • 95
    Xu B, Wagner N, Pham LN et al. Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, alpha4beta1 integrin/VCAM-1, and LFA-1 adhesion pathways. J Exp Med 2003; 197: 12551267.
  • 96
    Gauvreau GM, Becker AB, Boulet LP et al. The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. J Allergy Clin Immunol 2003; 112: 331338.
  • 97
    Chou YK, Edwards DM, Weinberg AD et al. Activation pathways implicate anti-HLA-DP and anti-LFA-1 antibodies as lead candidates for intervention in chronic berylliosis. J Immunol 2005; 174: 43164324.
  • 98
    Leonardi CL. Efalizumab: an overview. J Am Acad Dermatol 2003; 49: S98S104.
  • 99
    Stern RS. A promising step forward in psoriasis therapy. JAMA 2003; 290: 31333135.
  • 100
    Isobe M, Suzuki J, Yamazaki S et al. Regulation by differential development of Th1 and Th2 cells in peripheral tolerance to cardiac allograft induced by blocking ICAM-1/LFA-1 adhesion. Circulation 1997; 96: 22472253.